RX Drugs AND Medicare
Analysis: 1 in 4 Medicare Beneficiaries with Obesity or Overweight Could Be Eligible for Coverage of Wegovy
In this new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of Wegovy now that the FDA has approved the use of the anti-obesity drug to reduce the risk of heart attacks and stroke in certain patients.
Latest News
-
Millions Were Booted From Medicaid. The Insurers That Run It Gained Medicaid Revenue Anyway.
-
California Is Investing $500M in Therapy Apps for Youth. Advocates Fear It Won’t Pay Off.
-
Genetics Studies Have a Diversity Problem That Researchers Struggle To Fix
-
Mandatory Reporting Laws Meant To Protect Children Get Another Look
new and NOTABLE
-
Exceptions to State Abortion Bans and Early Gestational Limits
This policy tracker documents
exceptions in each state’s most restrictive gestational limit or total ban. -
What are the Implications of the Dobbs Ruling for Racial Disparities?
This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
-
At Current Staffing Levels, About 1 in 5 Nursing Facilities Would Meet New Minimum Standards
This analysis uses the most recently-available data to examine the percentage of nursing facilities that currently meet the minimum staffing requirements in the final rule.
-
Beyond the Data by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.